logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
6/13/2018 8:03:22 AM Samsung Bioepis And Biogen Announce Pooled Analysis Results Of Anti-TNF Biosimilars
6/13/2018 7:30:44 AM Biogen To Present Data From Its SPINRAZA Clinical Development Program
6/7/2018 7:31:21 AM Biogen Enters Exclusive Option Agreement With TMS To Acquire TMS-007 And Backup Compounds
6/5/2018 4:03:39 PM Ionis Pharmaceuticals Closes Strategic Collaboration With Biogen
5/31/2018 7:33:29 AM Biogen Appoints Daniel Karp As EVP, Corporate Development
5/1/2018 7:31:53 AM Biogen And Neurimmune Announce Option Exercise For Alzheimer’s Disease Investigational Treatment Aducanumab
4/24/2018 3:54:53 PM Jefferies Is Lowering Biogen Inc. (BIIB) FY19 Rev. Estimate To 13.02 Billion From 13.11 Billion
4/24/2018 3:54:38 PM Jefferies Is Lowering Biogen Inc. (BIIB) FY18 Rev. Estimate To 12.96 Billion From 12.97 Billion
4/24/2018 3:54:13 PM Jefferies Is Increasing Biogen Inc. (BIIB) FY19 Estimate To 25.94 From 25.04
4/24/2018 3:54:02 PM Jefferies Is Cutting Biogen Inc. (BIIB) FY18 Estimate To 23.73 From 24.64